image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Tarsus

April 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 120p
Results were well telegraphed by Tarsus' year-end update but the shares still spiked towards 12 month highs. For the year to 31 December, sales rose 35% to £57.5m, while adjusted pretax profit rose 36% to £14.6m. Net debt fell 10% to £30.7m, beating expectations. This has given it the confidence to acquire the remaining 20% of its US medical business, MCI, for £6.6m, as well as maintaining the 4p final dividend, giving 6p for the year.Tarsus reports across three geographical territories: Europe, US and Emerging Markets. Europe sales rose 14% to £26.7m, boosted by favourable forex swings and the inclusion of its large biennial event Labelexpo Brussels (sales up 14%), although France was weaker. In the US, sales fell 24% to £1 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X